WO2002061019A1 - Manufacturing method of pine charcoal and novel use thereof as an anticancer agent - Google Patents

Manufacturing method of pine charcoal and novel use thereof as an anticancer agent Download PDF

Info

Publication number
WO2002061019A1
WO2002061019A1 PCT/KR2001/000741 KR0100741W WO02061019A1 WO 2002061019 A1 WO2002061019 A1 WO 2002061019A1 KR 0100741 W KR0100741 W KR 0100741W WO 02061019 A1 WO02061019 A1 WO 02061019A1
Authority
WO
WIPO (PCT)
Prior art keywords
charcoal
pine
pine charcoal
prepared
furnace
Prior art date
Application number
PCT/KR2001/000741
Other languages
French (fr)
Inventor
Seng-Ha Hoang
Original Assignee
Seng-Ha Hoang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seng-Ha Hoang filed Critical Seng-Ha Hoang
Publication of WO2002061019A1 publication Critical patent/WO2002061019A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10BDESTRUCTIVE DISTILLATION OF CARBONACEOUS MATERIALS FOR PRODUCTION OF GAS, COKE, TAR, OR SIMILAR MATERIALS
    • C10B53/00Destructive distillation, specially adapted for particular solid raw materials or solid raw materials in special form
    • C10B53/02Destructive distillation, specially adapted for particular solid raw materials or solid raw materials in special form of cellulose-containing material
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D9/00Compositions of detergents based essentially on soap
    • C11D9/04Compositions of detergents based essentially on soap containing compounding ingredients other than soaps
    • C11D9/06Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/15Pinaceae (Pine family), e.g. pine or cedar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755Gymnosperms [Coniferophyta]
    • A61K8/9767Pinaceae [Pine family], e.g. pine or cedar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00Technologies for the production of fuel of non-fossil origin
    • Y02E50/10Biofuels, e.g. bio-diesel

Definitions

  • the present invention relates to a manufacturing method of pine charcoal and a novel use thereof as an anticancer agent.
  • the present invention relates to the use of the pine charcoal as a novel anticancer agent, wherein the pine charcoal is prepared with complete removal of tar by being carbonized with steam of 100°C injected into a stainless steal furnace of 850°C and the anticancer activity of the prepared charcoal, which means suppressing breast or liver cancer, is ascertained.
  • Cancer occurs through following three steps : initiation, promotion and progression.
  • Normal cells are mutated to abnormal cells by carcinogens, and as the abnormal cells increase in geometric progression, the cell division occurs abnormally, resulting in the cancer tissue.
  • Various anticancer agents for chemotherapy which have been developed until now, have toxicity to tumor cells, as well as normal cells, especially bone marrow cells or intestinal epithelium which, of body cells, show comparatively rapid growth. Because the toxicity of these anticancer agents leads to several adverse effects such as kidney intoxication, emesis, or neurotoxicity, other alternative therapies are needed.
  • the charcoal powder for medical use is very effective to eliminate harmful gases, useless proteins plumping human body, carcinogens and various chemicals from human body.
  • the charcoal powder which can be found in modern eating habits, makes in-food toxic substances dissolved and excreted, which have been accumulated in the body by eating the processed foodstuffs. This charcoal has been used in Korean and other oriental countries' traditional medicine, and we can find the use of this charcoal in the Korean or Chinese medical old books.
  • the Sunghaeyangbang it is described that a prescription containing the charcoal is applied to pains of muscles or joints; in “the Ch'ungumbang”, the charcoal powder is used in sudden choking of gullet; and as a folk remedy, the charcoal powder is used in diarrhea, influenza, and tympanitis (Kyungsun Lee, Study on the use of charcoal in folk remedies, 1987).
  • the study on the in vitro strong adsorption of activated charcoal to organic and inorganic compounds have been reported (Janes, W.H. et al. Chinical toxicology. 1975, 8:516-528), and now many studies on the use of charcoal based on its pharmacological action is actively progressing.
  • the present inventors have achieved the present invention, wherein the charcoal is prepared by the pine tree's being carbonized in high temperature to remove the tar component, and is confirmed that the prepared charcoal should have strong anticancer effect and no side-effect.
  • the present invention is intended to provide a therapeutic composition containing pine charcoal of an effective anticancer activity. Additionally, the present invention is intended to provide a manufacturing method of said pine charcoal.
  • the purpose of this invention was achieved through following manufacturing steps and activity tests of the inventive pine charcoal, comprising: pine trees were finely chopped in order to be evenly carbonized from the shell to interior of the pieces, and heated and carbonized in a stainless steel furnace of 850°C, together with the steam at 100°C injected into the furnace, and finally to the high-temperature-carbonized charcoal; prepared charcoal was tested in anticancer activity, compared to oak charcoal; in vivo anticancer activity test of the inventive charcoal was performed by transferring ascites cells to subcutaneous layer of mouse's groin, administering the pine charcoal powder to the mice for 4 weeks, and weighing the transferred tumor cells; to test its effect as an anticancer agent, the pine charcoal granule, which had been produced from the mixture of the prepared pine charcoal powder, eucalypt, olive oil, and brown rice leaves, was orally administered to a terminal cancer patient; to examine poison-neutralizing effect of the pine charcoal, the pine charcoal powder was administered to rats, 5 min after the rats were treated with various concentration of a
  • the present invention includes following steps, comprising: the step of finely chopping pine trees in size of 2-3 cm, heating/carbonizing the chopped pieces in a stainless steel furnace of 850°C, together with the steam of 100°C injected into the furnace for complete removal of the tar component, and finally refrigerating the prepared pine charcoal with liquid nitrogen; the step of preparing the charcoal granule after mixing lOOg of the charcoal powder with 5%(w/w) of eucalypt, 3%(w/w) of olive oil, and 0.01%(w/w) of brown rice leaves, wherein the charcoal powder may be prepared by pulverizing the prepared charcoal; the step of testing the prepared charcoal in its in vivo anticancer activity with comparing to oak charcoal; the step of measuring the charcoal's effect on inhibiting growth of solid cancers by administering the charcoal powder to the mice, which tumor cells were transferred to; the step of examining the change of cancer cells by X-ray and CT after the charcoal granule may be orally administered to breast or liver cancer patients at
  • the inventive manufacturing method of the charcoal includes coniferous pine trees, and of all kinds of pine trees, preferably red pine tree of 15-20 years old, which may actively secret anti-oxidizing agent the most.
  • the temperature in the carbonizing furnace may be between 600-1200°C, and preferably at 850°C with carbonizing a shade-drying pine tree.
  • the carbonized pine charcoal may be pulverized in
  • the herbicide used in the test of poison-neutralizing effect is diluted liquid s ⁇ ark(DONGBANG AGRO Corp.).
  • the inventive charcoal granule may be effective on irremediable patients with toxic chemicals, such as defoliant patients, patients poisoned with agricultural chemicals, or AIDS patients.
  • the high temperature-carbonized pine charcoal in powder form may be added to a usual toothpaste or soap for various functions, and mixed with conventional carriers, resulting in medicines in form of capsule, tablet or pill.
  • Figure 1 shows a schematic diagram of the manufacturing device for the inventive medical charcoal composition.
  • Figure 2 is a X-ray picture of a breast cancer patient at the terminal stage, whose right breast has been spoiled by the cancer cells.
  • Figure 3 is a X-ray picture of the breast cancer patient, whose cancer cells have been vanished by administering the inventive pine charcoal.
  • Figure 4 is a CT picture of a hepatoma patient at the terminal stage, who has irregular tumor.
  • Figure 5 is a CT picture of a hepatoma patient, whose tumor has been vanished by administering the inventive pine charcoal.
  • the manufacturing device for the inventive medical charcoal was used.
  • the manufacturing device consists of a stainless steal furnace(20) to contain the chopped pine tree; a heating device(30) at the bottom of said furnace; an inlet(l ⁇ ) for injecting steam; a liquid nitrogen tank(50) containing liquid nitrogen for sustaining its freshness by preventing oxidation of the charcoal; and an exit(40) for tar, through which the volatile tar, produced in carbonization of pine trees, may be discharged. Therefore, using the manufacturing device, the present inventors carbonized seasoned pine trees at 850°C and pulverized the carbonized pine charcoal in form of 120 mesh powder, wherein the seasoned pine trees was prepared by. seasoning pine trees in the shade for 15-30 days.
  • the charcoal produced by the above-mentioned method can be administered for long period because the inventive charcoal has no inhibition effect on extracellular secretion of such substances as digestive juice or hormones.
  • Another inventive charcoal powder which has no inactivating function unlike charcoal powder of other kinds of trees or activated charcoal, did not inhibit growth of the helpful intestinal bacteria, but suppressed intestinal noxious germ.
  • the charcoal prepared by the method described in Example 1 was pulverized to fine powder, and after mixing the prepared powder with 5%(w/w) of eucalypt, 3%(w/w) of olive oil, and 0.01%(w/w) of brown rice leaves, the granule was prepared using a granule-making device.
  • Example 1 As anticancer activity of the charcoal prepared as described in Example 1 was compared to a conventional oak charcoal, in vitro toxicity direct to tumor cell line was investigated.
  • the control compound was adriamycin, an anthraquinone anticancer agent.
  • MCF-7, MCF-7/ADR, the breast cancer cells and OVCAR-4's, the uterine cancer cells were cultured in EMEM, DMEM, and RPMI-1640 media containing 7.5% of FBS, referred to ATCC.
  • EMEM fetal calf serum
  • DMEM fetal calf serum
  • RPMI-1640 media containing 7.5% of FBS, referred to ATCC.
  • Each well of a plate was filled with lOO ⁇ l of the tumor cells in the concentration of lxl0 2 / ⁇ l, and in each well, pine charcoal, oak charcoal, or adriamycin as a control were added in various concentration. After this, the plate was incubated at 37°C in 5% of CO 2 for 2 days, and toxic activity for each cell line was presented in ED 50 , the concentration in which cell growth may be inhibited to extent of 50%, compared to tumor growth of control group.
  • the oak charcoal in this experiment has the same mesh of its particle with the pine charcoal, the oak charcoal may have high hardness, sharp surface, and low absorption into humor, resulting in its accumulation in the cell wall of intestinal tissue instead of its proper working. Therefore, the accumulation of the charcoal in the cell wall caused by long-period taking of the oak charcoal can lead to damage of the cell tissue, seriously loss of colonic function.
  • the inventive pine charcoal has low hardness and high absorption into humor. Further, the inventive pine charcoal has a different C-C bond structure as compared with any other kinds of the arbor, i.e. the oak after being carbonized, because it has a large quantity of essential amino acids contained in the stem.
  • the charcoal prepared in Example 1 had been administered to several groups of mice for 3 weeks, and it was checked that similar amount of the charcoal had been uptaken to each group.
  • the antitumor activity of the pine charcoal was measured by following steps : transferring 7 day-grown ascites cells (sarcoma- 180) to subcutaneous layer of mouse's groin; administering various amount of the pine charcoal powder to each group of mice for 4 weeks; killing the mice by means of luxation of the cervical vertebrae; weighing the isolated tumor cells; and calculating tumor growth inhibition ratio % as following equation.
  • A is the average tumor weight of the control group
  • B is the average tumor weight of the treated group.
  • Tumor growth inhibition ratio (%) ( A - B )/A x 100
  • the cancer weight of the control group was 3.72g, and that of the group, which had been treated with the pine charcoal, was decreased in proportion to treated amount of the charcoal powder.
  • the weight of mouse uptaken with 2%(dietary w/w) of the pine charcoal was 2.37 g, which means 36.2% of inhibition ratio compared to the control group, and the weight of mouse uptaken with 5%(w/w) was 1.22g, meaning 67.2% of inhibition ratio. Consequently, it is confirmed that the inhibition ratio be in proportion to the uptake amount of the inventive charcoal.
  • the object of this test was a patient, Ahn Soonja(Citizen JJD : 440820- 2047826), who, after treated with chemotherapy 5 times after diagnosis of breast cancer at Kyunghee Medical Center in Aug. 2000, had still suffered from tumor cells, who could hardly eat something, and who had been finally pronounced to have 3 months remaining for her life.
  • the right side had been seriously occupied with tumor cell.
  • the present inventor had administered the patient the granule prepared in Example 2 for 3 months, and observed change of the tumor cell using X-ray.
  • the right side breast cancer had almost vanished as shown in Fig. 3, and blood test was also clean, so a decision of complete recovery was made.
  • This anti-poison effect of the charcoal can be explained like the pine charcoal eliminates the activity of the poison from the gastrointestines by sudden absorption of the herbicide. Also we can see that if compared to usual oak charcoal, the inventive pine charcoal shows higher anti-poison effect by 2-2.5 times.
  • the object of this test was a patient, Ahn Jinho(Citizen ID : 490915- 1408516) who had been announced to have diabetes and chronic renal failure at the Catholic University of Korea, Taejon St. Mary's Hospital in Sep. 16, 1998, who could not do usual activity, and to whom the granule prepared in Example 2 had been administered for 1 year.
  • the patient's weight had changed from 45 kg to 53 kg, the normal weight, and his blood sugar and blood lipid concentration became normal. According to this result, it has been proved that with the inventive pine charcoal, the diabetes can be treated.
  • the charcoal content exceeds 15%(w/w) in total soap content, cracking of the soap can be observed in molding step, and for this reason, it is recommended that the charcoal content should be between 1 and 15%(w/w), and most preferably 5%(w/w).
  • the carbonized pine charcoal has micropores formed with removal of air by heating and the adsorption ability of the pine charcoal originates from the micropores. Therefore, by manufacture of a soap using this pine charcoal, the efficacy of adsorption of waste material can be acquired, and contrary to other porous materials, this inventive charcoal comprises carbon. So in application to skin, the osmotic phenomenon, which can occur because of pH-change of the skin, does not occur and this product can be applied to all types of skin such as dry, normal, and oily skin.
  • the pine charcoal tooth pastes was prepared by mixing 10%(w/w) of the pine charcoal (120 mesh) in Example 1 with a conventional toothpaste composition, which contains sorbitol (40%(w/w)), distilled water (30%(w/w)); 2%(w/w) of poly ethylene glycol (MW 950-1,600) as a moisturizer; l%(w/w) of sodium carboxymethylcellulose as a gelling agent; 1.5%(w/w) of sodium laurylsulfate as a organic surfactant; 8.4%(w/w) of calcium carbonate as a inaqueous brightener used in the dental pharmaceutics; 6.0%(w/w) of silica; 0.1%(w/w) of maltose and 1.0%(w/w) of peppermint as a sweetener and spice.
  • a conventional toothpaste composition which contains sorbitol (40%(w/w)), distilled water (30%(w/w)); 2%(w/w) of poly ethylene glycol
  • the pine charcoal has an intraoral antimicrobial or anti-inflammatory effect; no irritating action to the oral cells; and further efficacies such as preventing periodontal diseases and treating halitosis and xerostomia. Also, methane gas or ozostomia from the intestines and foul breath caused by the remnants in the mouth can be removed by strong adsorption of the pine charcoal.
  • the pine charcoal in this invention can be prepared in the product for oral administration; administrating the pine charcoal to the patients having terminal breast or liver cancer in approval of themselves or their protectors, leads to its excellent cancer-therapeutic activity, such as effectively suppressing the proliferation and transition of malignant tumor cells; and the health cleaning necessities can be provided by incorporating the pine charcoal with conventional soap or toothpaste composition.
  • inventive pine charcoal is very useful to the biomedical and pharmaceutical industries.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to a manufacturing method of pine charcoal and novel use thereof as an anticancer agent. The pine charcoal of the present invention is very efficacious in treating cancer as an anticancer agent, as the said pine charcoal is carbonized with 100°C steam in an 850°C airtight stainless steal furnace and then tars in the pine charcoal are eliminated completely.

Description

MANUFACTURING METHOD OF PINE CHARCOAL AND NOVEL USE THEREOF AS AN ANTICANCER AGENT
TECHNICAL FIELD
The present invention relates to a manufacturing method of pine charcoal and a novel use thereof as an anticancer agent. In detail, the present invention relates to the use of the pine charcoal as a novel anticancer agent, wherein the pine charcoal is prepared with complete removal of tar by being carbonized with steam of 100°C injected into a stainless steal furnace of 850°C and the anticancer activity of the prepared charcoal, which means suppressing breast or liver cancer, is ascertained.
BACKGROUND ART
Cancer occurs through following three steps : initiation, promotion and progression. Normal cells are mutated to abnormal cells by carcinogens, and as the abnormal cells increase in geometric progression, the cell division occurs abnormally, resulting in the cancer tissue. Various anticancer agents for chemotherapy, which have been developed until now, have toxicity to tumor cells, as well as normal cells, especially bone marrow cells or intestinal epithelium which, of body cells, show comparatively rapid growth. Because the toxicity of these anticancer agents leads to several adverse effects such as kidney intoxication, emesis, or neurotoxicity, other alternative therapies are needed.
It is known that by its strong adsorption ability, the charcoal powder for medical use is very effective to eliminate harmful gases, useless proteins plumping human body, carcinogens and various chemicals from human body. Also the charcoal powder, which can be found in modern eating habits, makes in-food toxic substances dissolved and excreted, which have been accumulated in the body by eating the processed foodstuffs. This charcoal has been used in Korean and other oriental countries' traditional medicine, and we can find the use of this charcoal in the Korean or Chinese medical old books. For examples, in "the Sunghaeyangbang", it is described that a prescription containing the charcoal is applied to pains of muscles or joints; in "the Ch'ungumbang", the charcoal powder is used in sudden choking of gullet; and as a folk remedy, the charcoal powder is used in diarrhea, influenza, and tympanitis (Kyungsun Lee, Study on the use of charcoal in folk remedies, 1987). Moreover, the study on the in vitro strong adsorption of activated charcoal to organic and inorganic compounds have been reported (Janes, W.H. et al. Chinical toxicology. 1975, 8:516-528), and now many studies on the use of charcoal based on its pharmacological action is actively progressing.
Prior patents of the charcoal powder are on the activated charcoal as an antidote (US Patent No. 5,681,564), and on manufacturing method of the activated charcoal (US Patent No. 5,391,534). However, the methods disclosed in said patents include too many compounds, and when administered into human body, the charcoal power works intestinal humor.
Until now any study on anticancer activity of the pine charcoal has not been made, and it has never been reported that the pine charcoal might suppress the transference of solid cancer, especially prevent and suppress the transference of breast carcinoma. Furthermore, usual charcoal in folk remedies or activated charcoal in the market has been used in an edible form, but the former is not suitable to long- period taking because of the residual tar component and the precipitation of the charcoal in human intestine, and the latter has strong inhibition against intestinal humor, for examples, digestive juice, hormones, and blood, causing rapid decrease of the stamina in case of patients or children, so as the results, long-period taking is not acceptable and the intended effect cannot be obtained.
Considering said problems in prior arts, the present inventors have achieved the present invention, wherein the charcoal is prepared by the pine tree's being carbonized in high temperature to remove the tar component, and is confirmed that the prepared charcoal should have strong anticancer effect and no side-effect. The present invention is intended to provide a therapeutic composition containing pine charcoal of an effective anticancer activity. Additionally, the present invention is intended to provide a manufacturing method of said pine charcoal.
DISCLOSURE OF THE INVENTION
The purpose of this invention was achieved through following manufacturing steps and activity tests of the inventive pine charcoal, comprising: pine trees were finely chopped in order to be evenly carbonized from the shell to interior of the pieces, and heated and carbonized in a stainless steel furnace of 850°C, together with the steam at 100°C injected into the furnace, and finally to the high-temperature-carbonized charcoal; prepared charcoal was tested in anticancer activity, compared to oak charcoal; in vivo anticancer activity test of the inventive charcoal was performed by transferring ascites cells to subcutaneous layer of mouse's groin, administering the pine charcoal powder to the mice for 4 weeks, and weighing the transferred tumor cells; to test its effect as an anticancer agent, the pine charcoal granule, which had been produced from the mixture of the prepared pine charcoal powder, eucalypt, olive oil, and brown rice leaves, was orally administered to a terminal cancer patient; to examine poison-neutralizing effect of the pine charcoal, the pine charcoal powder was administered to rats, 5 min after the rats were treated with various concentration of a herbicide; the pine charcoal was administered to patients with diabetes or chronic renal failure; and a pine charcoal toothpaste and pine charcoal soap was manufactured via adding the pine charcoal to usual toothpastes and soaps, respectively.
The present invention is described by following detailed description.
The present invention includes following steps, comprising: the step of finely chopping pine trees in size of 2-3 cm, heating/carbonizing the chopped pieces in a stainless steel furnace of 850°C, together with the steam of 100°C injected into the furnace for complete removal of the tar component, and finally refrigerating the prepared pine charcoal with liquid nitrogen; the step of preparing the charcoal granule after mixing lOOg of the charcoal powder with 5%(w/w) of eucalypt, 3%(w/w) of olive oil, and 0.01%(w/w) of brown rice leaves, wherein the charcoal powder may be prepared by pulverizing the prepared charcoal; the step of testing the prepared charcoal in its in vivo anticancer activity with comparing to oak charcoal; the step of measuring the charcoal's effect on inhibiting growth of solid cancers by administering the charcoal powder to the mice, which tumor cells were transferred to; the step of examining the change of cancer cells by X-ray and CT after the charcoal granule may be orally administered to breast or liver cancer patients at the terminal stage; the step of comparing poison-neutralizing effects of the pine charcoal on rats, to which the pine charcoal powder may be administered, 5 min after treating the rats with various concentration of a herbicide;
- the step of examining effects of the inventive pine charcoal on patients with diabetes or chronic renal failure; and the step of manufacturing a pine charcoal toothpaste and pine charcoal soap via adding the pine charcoal to usual toothpastes and soaps, respectively.
The inventive manufacturing method of the charcoal includes coniferous pine trees, and of all kinds of pine trees, preferably red pine tree of 15-20 years old, which may actively secret anti-oxidizing agent the most. In the present invention, the temperature in the carbonizing furnace may be between 600-1200°C, and preferably at 850°C with carbonizing a shade-drying pine tree.
In the present invention, the carbonized pine charcoal may be pulverized in
100-500 mesh of powder, preferably in 120 mesh. In the present invention, the herbicide used in the test of poison-neutralizing effect is diluted liquid sρark(DONGBANG AGRO Corp.).
The inventive charcoal granule may be effective on irremediable patients with toxic chemicals, such as defoliant patients, patients poisoned with agricultural chemicals, or AIDS patients. In the present invention, the high temperature-carbonized pine charcoal in powder form may be added to a usual toothpaste or soap for various functions, and mixed with conventional carriers, resulting in medicines in form of capsule, tablet or pill.
The present invention is illustrated but in no way limited by the following examples.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 shows a schematic diagram of the manufacturing device for the inventive medical charcoal composition.
Figure 2 is a X-ray picture of a breast cancer patient at the terminal stage, whose right breast has been spoiled by the cancer cells.
Figure 3 is a X-ray picture of the breast cancer patient, whose cancer cells have been vanished by administering the inventive pine charcoal.
Figure 4 is a CT picture of a hepatoma patient at the terminal stage, who has irregular tumor.
Figure 5 is a CT picture of a hepatoma patient, whose tumor has been vanished by administering the inventive pine charcoal.
EXAMPLES
Example 1
Production of high temperature-carbonized charcoal of pine trees To produce high temperature-carbonized charcoal, as described in Fig. 1, the manufacturing device for the inventive medical charcoal was used. The manufacturing device consists of a stainless steal furnace(20) to contain the chopped pine tree; a heating device(30) at the bottom of said furnace; an inlet(lθ) for injecting steam; a liquid nitrogen tank(50) containing liquid nitrogen for sustaining its freshness by preventing oxidation of the charcoal; and an exit(40) for tar, through which the volatile tar, produced in carbonization of pine trees, may be discharged. Therefore, using the manufacturing device, the present inventors carbonized seasoned pine trees at 850°C and pulverized the carbonized pine charcoal in form of 120 mesh powder, wherein the seasoned pine trees was prepared by. seasoning pine trees in the shade for 15-30 days.
Compared to other charcoal produced at higher or lower temperature than said temperature, the charcoal produced by the above-mentioned method can be administered for long period because the inventive charcoal has no inhibition effect on extracellular secretion of such substances as digestive juice or hormones. Another inventive charcoal powder, which has no inactivating function unlike charcoal powder of other kinds of trees or activated charcoal, did not inhibit growth of the helpful intestinal bacteria, but suppressed intestinal noxious germ. Example 2
Manufacturing the anticancer composition using the inventive pine charcoal
The charcoal prepared by the method described in Example 1 was pulverized to fine powder, and after mixing the prepared powder with 5%(w/w) of eucalypt, 3%(w/w) of olive oil, and 0.01%(w/w) of brown rice leaves, the granule was prepared using a granule-making device.
Example 3
Examining anticancer effect of the inventive pine charcoal Anticancer activity of the charcoal prepared as described in Example 1 was tested in vivo and in vitro. The toxic activity of the inventive pine charcoal on tumor cell line and normal cell line was examined, and the effect of preventing the solid cancer was tested for the mice induced to have solid cancer.
Experiment 1 : Comparing the inventive pine charcoal with oak charcoal in in vitro anticancer activity
As anticancer activity of the charcoal prepared as described in Example 1 was compared to a conventional oak charcoal, in vitro toxicity direct to tumor cell line was investigated. The control compound was adriamycin, an anthraquinone anticancer agent.
MCF-7, MCF-7/ADR, the breast cancer cells and OVCAR-4's, the uterine cancer cells were cultured in EMEM, DMEM, and RPMI-1640 media containing 7.5% of FBS, referred to ATCC. Each well of a plate was filled with lOOμl of the tumor cells in the concentration of lxl02/μl, and in each well, pine charcoal, oak charcoal, or adriamycin as a control were added in various concentration. After this, the plate was incubated at 37°C in 5% of CO2 for 2 days, and toxic activity for each cell line was presented in ED50, the concentration in which cell growth may be inhibited to extent of 50%, compared to tumor growth of control group. As the experimental result was showed in Table 1, in the cell-toxicity, 48 hr after administering the samples to each kind of tumor cells, the pine charcoal showed similar activity with adriamycin and 2-5 fold higher activity than the oak charcoal. As disclosed in the experiments for NIH3T3, adriamycin(an anticancer agent) has the cell-toxicity for normal as well as tumor cell line, while the pine charcoal has toxic activity for tumor cells and specifically no toxic activity for normal cells.
Table 1
Toxic activity of the inventive pine charcoal for tumor cell line
Figure imgf000009_0001
Furthermore, even if the oak charcoal in this experiment has the same mesh of its particle with the pine charcoal, the oak charcoal may have high hardness, sharp surface, and low absorption into humor, resulting in its accumulation in the cell wall of intestinal tissue instead of its proper working. Therefore, the accumulation of the charcoal in the cell wall caused by long-period taking of the oak charcoal can lead to damage of the cell tissue, seriously loss of colonic function.
The inventive pine charcoal has low hardness and high absorption into humor. Further, the inventive pine charcoal has a different C-C bond structure as compared with any other kinds of the arbor, i.e. the oak after being carbonized, because it has a large quantity of essential amino acids contained in the stem.
Experiment 2 : Measuring effect of the inventive pine charcoal on solid tumor growth inhibition
The charcoal prepared in Example 1 had been administered to several groups of mice for 3 weeks, and it was checked that similar amount of the charcoal had been uptaken to each group. The antitumor activity of the pine charcoal was measured by following steps : transferring 7 day-grown ascites cells (sarcoma- 180) to subcutaneous layer of mouse's groin; administering various amount of the pine charcoal powder to each group of mice for 4 weeks; killing the mice by means of luxation of the cervical vertebrae; weighing the isolated tumor cells; and calculating tumor growth inhibition ratio % as following equation. In this equation, A is the average tumor weight of the control group, and B is the average tumor weight of the treated group.
Tumor growth inhibition ratio (%) = ( A - B )/A x 100
Table 2
Antitumor activity of the pine charcoal in mice transferred with sarcoma- 180
Figure imgf000010_0001
As described in Table 1, the cancer weight of the control group was 3.72g, and that of the group, which had been treated with the pine charcoal, was decreased in proportion to treated amount of the charcoal powder. The weight of mouse uptaken with 2%(dietary w/w) of the pine charcoal was 2.37 g, which means 36.2% of inhibition ratio compared to the control group, and the weight of mouse uptaken with 5%(w/w) was 1.22g, meaning 67.2% of inhibition ratio. Consequently, it is confirmed that the inhibition ratio be in proportion to the uptake amount of the inventive charcoal.
Example 4 Clinical tests on various kinds of tumors using the inventive pine charcoal
Of the patients who had suffered from breast or liver cancer and had less than 1 year of survival time, volunteers approved by themselves or his/her protectors were selected to clinically examine the antitumor activity of the pine charcoal granule prepared by the method in Example 2. The inventive charcoal granule was administered in 3 times/day.
Experiment 1 : Clinical test on a breast cancer patient
The object of this test was a patient, Ahn Soonja(Citizen JJD : 440820- 2047826), who, after treated with chemotherapy 5 times after diagnosis of breast cancer at Kyunghee Medical Center in Aug. 2000, had still suffered from tumor cells, who could hardly eat something, and who had been finally pronounced to have 3 months remaining for her life. As shown in Fig. 2, the right side had been seriously occupied with tumor cell. The present inventor had administered the patient the granule prepared in Example 2 for 3 months, and observed change of the tumor cell using X-ray. As the results, the right side breast cancer had almost vanished as shown in Fig. 3, and blood test was also clean, so a decision of complete recovery was made.
Experiment 2 : Clinical test on a liver cancer patient The object of this test was a patient, Jeon Suok(Citizen ID : 401113-
1347915) who had been pronounced to have liver cancer at the terminal stage at Ewha Womans University Medical Center on Oct. 30, 1999. When leaving hospital, she had large tumor cell as shown in the CT picture of Fig. 4. The present inventor had administered the patient the granule prepared in Example 2 for 8 months, and observed change of the tumor cell using CT picture. As the results, the tumor cell had completely disappeared as shown in Fig. 5.
Example 5
Examining anti-poison effect of the inventive pine charcoal
Anti-poison effect of the pine charcoal prepared in Example 1 was examined. 3 g of the pine charcoal powder and conventional oak charcoal powder were respectively mixed with 3 ml of saline and administered to rats with 260g of average weight, 5 min after 1 ml, 3 ml, and 7 ml of the diluted liquid herbicide(Spark liquid agent, DONGBANG AGRO Corp.) had been independently injected to them. Each experimental group include 20 members of rats, and the percentage of survival was measured, 1 hr after administration of the charcoal powder. The liquid herbicide as above-mentioned contains glyphosate-ammonium, a surfactant, a solvent as valid composition, and was used in 200-fold dilution.
As the results shown in Table 3, the group to which the charcoal had not been administered was completely killed by 7 ml of herbicide, while rats to which the charcoal had been administered had high survival %.
This anti-poison effect of the charcoal can be explained like the pine charcoal eliminates the activity of the poison from the gastrointestines by sudden absorption of the herbicide. Also we can see that if compared to usual oak charcoal, the inventive pine charcoal shows higher anti-poison effect by 2-2.5 times.
Table 3 Anti-poison effect of the pine charcoal on herbicide-poisoned rats
Figure imgf000012_0001
Figure imgf000013_0001
Example 6
Clinical test on a diabetic
The object of this test was a patient, Ahn Jinho(Citizen ID : 490915- 1408516) who had been announced to have diabetes and chronic renal failure at the Catholic University of Korea, Taejon St. Mary's Hospital in Sep. 16, 1998, who could not do usual activity, and to whom the granule prepared in Example 2 had been administered for 1 year. After the treatment, the patient's weight had changed from 45 kg to 53 kg, the normal weight, and his blood sugar and blood lipid concentration became normal. According to this result, it has been proved that with the inventive pine charcoal, the diabetes can be treated.
Example 7
Manufacture of a soap containing the inventive pine charcoal powder The pine charcoal powder (120 mesh) and a conventional soap composition were blended at the ratio 5:95, and then the mixture was extruded at 95°C to be molded in a soap frame, wherein the conventional soap composition included palm oil (81.5%(w/w)), glycerin (1.2%(w/w)), squalene (0.5%(w/w)), tocopherol (0.5%(w/w)), perfume (1.2%(w/w)), glycerol (1.0%(w/w)), water (13.5%(w/w)), CaCl(0.6%(w/w)), and alkali component (0.05%(w/w)).
When the charcoal content exceeds 15%(w/w) in total soap content, cracking of the soap can be observed in molding step, and for this reason, it is recommended that the charcoal content should be between 1 and 15%(w/w), and most preferably 5%(w/w).
The carbonized pine charcoal has micropores formed with removal of air by heating and the adsorption ability of the pine charcoal originates from the micropores. Therefore, by manufacture of a soap using this pine charcoal, the efficacy of adsorption of waste material can be acquired, and contrary to other porous materials, this inventive charcoal comprises carbon. So in application to skin, the osmotic phenomenon, which can occur because of pH-change of the skin, does not occur and this product can be applied to all types of skin such as dry, normal, and oily skin.
Example 8
Manufacture of a toothpaste containing the inventive pine charcoal
The pine charcoal tooth pastes was prepared by mixing 10%(w/w) of the pine charcoal (120 mesh) in Example 1 with a conventional toothpaste composition, which contains sorbitol (40%(w/w)), distilled water (30%(w/w)); 2%(w/w) of poly ethylene glycol (MW 950-1,600) as a moisturizer; l%(w/w) of sodium carboxymethylcellulose as a gelling agent; 1.5%(w/w) of sodium laurylsulfate as a organic surfactant; 8.4%(w/w) of calcium carbonate as a inaqueous brightener used in the dental pharmaceutics; 6.0%(w/w) of silica; 0.1%(w/w) of maltose and 1.0%(w/w) of peppermint as a sweetener and spice.
The pine charcoal has an intraoral antimicrobial or anti-inflammatory effect; no irritating action to the oral cells; and further efficacies such as preventing periodontal diseases and treating halitosis and xerostomia. Also, methane gas or ozostomia from the intestines and foul breath caused by the remnants in the mouth can be removed by strong adsorption of the pine charcoal. INDUSTRIAL APPLICABILITY
As above described in the examples and experiments, the pine charcoal in this invention can be prepared in the product for oral administration; administrating the pine charcoal to the patients having terminal breast or liver cancer in approval of themselves or their protectors, leads to its excellent cancer-therapeutic activity, such as effectively suppressing the proliferation and transition of malignant tumor cells; and the health cleaning necessities can be provided by incorporating the pine charcoal with conventional soap or toothpaste composition. Thus the inventive pine charcoal is very useful to the biomedical and pharmaceutical industries.

Claims

WHAT IS CLAIMED IS:
1. A manufacturing method for a pine charcoal as following steps, comprising: chopping pine trees finely; heating/carbonizing the chopped pieces in a stainless steel furnace of 850°C, together with steam mjected into the furnace for complete removal of the tar component; and finally refrigerating the prepared pine charcoal with liquid nitrogen.
2. The pine charcoal prepared using the method according to claim 1.
3. A therapeutic anticancer composition, comprising the pine charcoal according to claim 1 as an effective component.
4. A soap composition, comprising l-20%(w/w) of the pine charcoal according to claim 1.
5. A toothpaste composition, comprising l-15%(w/w) of the pine charcoal according to claim 1.
6. A manufacturing device for the pine charcoal, comprising: a stainless steal furnace(20) to contain the chopped pine tree; a heating device(30) at the bottom of said furnace; an inlet(lθ) for injecting steam; a liquid nitrogen tank(50) containing liquid nitrogen for sustaining its freshness by preventing oxidation of the charcoal; and an exit(40) for tar, through which the volatile tar, produced in carbonization of pine trees, can be discharged.
PCT/KR2001/000741 2001-02-01 2001-05-08 Manufacturing method of pine charcoal and novel use thereof as an anticancer agent WO2002061019A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR2001/4941 2001-02-01
KR1020010004941A KR20020064471A (en) 2001-02-01 2001-02-01 Manufacturing method of pine charcoal and novel use thereof as an anticancer agent

Publications (1)

Publication Number Publication Date
WO2002061019A1 true WO2002061019A1 (en) 2002-08-08

Family

ID=19705220

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2001/000741 WO2002061019A1 (en) 2001-02-01 2001-05-08 Manufacturing method of pine charcoal and novel use thereof as an anticancer agent

Country Status (2)

Country Link
KR (1) KR20020064471A (en)
WO (1) WO2002061019A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111303956A (en) * 2020-04-27 2020-06-19 骆家辉 Clean and efficient biomass fuel and preparation method thereof
CN112689517A (en) * 2018-08-05 2021-04-20 达·沃尔泰拉公司 Method for improving the efficacy of anticancer agents

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020026789A (en) * 2000-10-02 2002-04-12 오인규 Method for manufacturing charcoal having strong heating power and product using it made from said method
KR100457820B1 (en) * 2001-06-08 2004-11-18 차순옥 The manufacturing process of edible carbon using pine charcoal
KR100457821B1 (en) * 2001-06-08 2004-11-18 차순옥 The manufacturing process of edible charcoal using pine charcoal
RU2578695C2 (en) * 2014-07-02 2016-03-27 Общество с ограниченной ответственностью Научно-Технический Центр "Химинвест" Method of producing pine tar
KR101720187B1 (en) * 2016-08-30 2017-03-28 박순용 Skin external preparation composition for removing black mole comprising flaming coal powder and fine charcoal powder extract

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990046650A (en) * 1999-04-10 1999-07-05 이수응 a cleanser soap devise
KR20010001394A (en) * 1999-06-03 2001-01-05 차현석 Pine Medicunal Carbon Granulate
KR20010011879A (en) * 1999-07-30 2001-02-15 홍성호 Manufacturing process of charcal toothpaste.
KR20010010422A (en) * 1999-07-20 2001-02-15 안재주 Dentifrice used charcoal

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100458488B1 (en) * 1998-11-10 2005-01-24 안정오 Method for producing charcoal containing silver

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990046650A (en) * 1999-04-10 1999-07-05 이수응 a cleanser soap devise
KR20010001394A (en) * 1999-06-03 2001-01-05 차현석 Pine Medicunal Carbon Granulate
KR20010010422A (en) * 1999-07-20 2001-02-15 안재주 Dentifrice used charcoal
KR20010011879A (en) * 1999-07-30 2001-02-15 홍성호 Manufacturing process of charcal toothpaste.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112689517A (en) * 2018-08-05 2021-04-20 达·沃尔泰拉公司 Method for improving the efficacy of anticancer agents
CN111303956A (en) * 2020-04-27 2020-06-19 骆家辉 Clean and efficient biomass fuel and preparation method thereof

Also Published As

Publication number Publication date
KR20020064471A (en) 2002-08-09

Similar Documents

Publication Publication Date Title
WO2006013420A2 (en) Mixture of catechins or rather polyphenols extracted from chinese green tea or other vegetables for the prevention of prostate cancer and for the treatment of prostate hypertrophy (bph)
KR20160050108A (en) Compositions for Improving Oral Hygiene comprising extracts derived from natural materials and Uses Thereof
WO2015024218A1 (en) Pharmaceutical composition, preparation method therefor and use thereof
WO2002061019A1 (en) Manufacturing method of pine charcoal and novel use thereof as an anticancer agent
KR101015860B1 (en) Pharmaceutical composition for treating cancers comprising fermented liquid from gastrodia elata blume and recipe of the same
JP4728469B2 (en) Hepatoprotective agent with antioxidant activity
KR101045025B1 (en) Pharmaceutical composition for preventing or treatment of asthma
KR20140036822A (en) Manufacturing method of a functional composition for preventing cancer containing chive extrect, a functional composition for preventing cancer containing chive extrect manufactured by the same and a functional food for preventing cancer containing therof
JP4644834B2 (en) Α-amylase inhibitor, α-glucosidase inhibitor, glucose absorption inhibitor and use thereof
KR100853939B1 (en) Composition for hangover containing leaf of capsicum annuum
TWI712417B (en) Composition for moistening bowel and laxative and its application and functional food
CN110279025A (en) A kind of apple polyphenol health chewing gum and preparation method thereof
KR100364390B1 (en) Compositions for the treatment of diabetes
CN108125237B (en) Health product for relieving cough, eliminating phlegm and resisting inflammation and preparation process thereof
KR101413771B1 (en) A composition for anti-obesity comprising extract of big cone pine needle
CN110692984A (en) Rose chewable tablet for removing oral odor and preparation method thereof
KR20210097487A (en) Composition for preventing, improving or treating sleep disorders comprising fucoidan
KR102412392B1 (en) Cheongwitang Composition
KR102454544B1 (en) Method for producing a Cervus Parvum Cornu Hydrolyzate containing a large amount of IGF and its use
JP2003073289A (en) Active oxygen scavenger
KR20050104091A (en) Eleutheroside e having bone growth-promoting effects and functional foods or pharmaceutical preparations containing the same
KR20120090123A (en) Composition of film forming solution for alleviation of menstrual cramp
KR20060026938A (en) Pharmacuetical compositions comprising eleutheroside e having bone growth-promoting effects
JP2007145731A (en) Pharmaceutical preparation for oral administration having stegnotic effect
JP2016193844A (en) Dryopteridaceae plant-containing composition

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP